Literature DB >> 12600862

Effect of the methylenetetrahydrofolate reductase 677C-->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample.

Angelika de Bree1, W M Monique Verschuren, Anne-Lise Bjørke-Monsen, Nathalie M J van der Put, Sandra G Heil, Frans J M Trijbels, Henk J Blom.   

Abstract

BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in folate and homocysteine metabolism. The common MTHFR 677C-->T polymorphism decreases the enzyme's activity.
OBJECTIVE: The objective of the study was to assess the effect of the polymorphism on the relations among folate intake, plasma folate concentration, and total plasma homocysteine (tHcy) concentration.
DESIGN: The design was a cross-sectional analysis in a random sample (n = 2051) of a Dutch cohort (aged 20-65 y).
RESULTS: At a low folate intake (166 micro g/d), folate concentrations differed significantly among the genotypes (7.1, 6.2, and 5.4 nmol/L for the CC, CT, and TT genotypes, respectively; P for all comparisons < 0.05). At a high folate intake (250 microg/d), folate concentrations in CT and CC subjects did not differ significantly (8.3 and 8.6 nmol/L, respectively, but were significantly higher (P = 0.2) than those in TT subjects (7.3 nmol/L; P = 0.04). At a low folate concentration (4.6 nmol/L), TT subjects had a significantly higher (P = 0.0001) tHcy concentration than did CC and CT subjects (20.3 compared with 15.0 and 14.1 micromol/L, respectively), whereas at a high folate concentration (11.9 nmol/L), the tHcy concentration did not differ significantly between genotypes (P > 0.2; <13.1 for all genotypes). The relation between folate intake and tHcy concentration had a pattern similar to that of the relation between plasma folate and tHcy concentrations.
CONCLUSIONS: At any folate intake level, TT subjects have lower plasma folate concentrations than do CT and CC subjects. Yet, at high plasma folate concentrations, tHcy concentrations in TT subjects are as low as those in CT and CC subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12600862     DOI: 10.1093/ajcn/77.3.687

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  35 in total

1.  Risk of retinoblastoma is associated with a maternal polymorphism in dihydrofolatereductase (DHFR) and prenatal folic acid intake.

Authors:  Manuela A Orjuela; Lourdes Cabrera-Muñoz; Ligi Paul; Marco A Ramirez-Ortiz; Xinhua Liu; Jia Chen; Fabiola Mejia-Rodriguez; Aurora Medina-Sanson; Silvia Diaz-Carreño; Ida H Suen; Jacob Selhub; M Veronica Ponce-Castañeda
Journal:  Cancer       Date:  2012-05-30       Impact factor: 6.860

2.  MTHFR C677T genotype and cardiovascular risk in a general population without mandatory folic acid fortification.

Authors:  Lise Lotte N Husemoen; Tea Skaaby; Torben Jørgensen; Betina H Thuesen; Mogens Fenger; Niels Grarup; Camilla H Sandholt; Torben Hansen; Oluf Pedersen; Allan Linneberg
Journal:  Eur J Nutr       Date:  2014-01-24       Impact factor: 5.614

3.  MTHFR 677T is a strong determinant of the degree of hearing loss among Polish males with postlingual sensorineural hearing impairment.

Authors:  Agnieszka Pollak; Malgorzata Mueller-Malesinska; Urszula Lechowicz; Agata Skorka; Lech Korniszewski; Agnieszka Sobczyk-Kopciol; Anna Waskiewicz; Grazyna Broda; Katarzyna Iwanicka-Pronicka; Monika Oldak; Henryk Skarzynski; Rafał Płoski
Journal:  DNA Cell Biol       Date:  2012-03-16       Impact factor: 3.311

4.  Lack of association between the MTHFR C677T variant and migraine with aura in an older population: could selective survival play a role?

Authors:  Ann I Scher; Gudny Eiriksdottir; Melissa Garcia; Preethy Feit; Albert V Smith; Tamara B Harris; Kathryn A Roecklein; Larus S Gudmundsson; Vilmundur Gudnason; Lenore J Launer
Journal:  Cephalalgia       Date:  2012-12-10       Impact factor: 6.292

5.  Status of vitamins B-12 and B-6 but not of folate, homocysteine, and the methylenetetrahydrofolate reductase C677T polymorphism are associated with impaired cognition and depression in adults.

Authors:  Denish Moorthy; Inga Peter; Tammy M Scott; Laurence D Parnell; Chao-Qiang Lai; Jimmy W Crott; José M Ordovás; Jacob Selhub; John Griffith; Irwin H Rosenberg; Katherine L Tucker; Aron M Troen
Journal:  J Nutr       Date:  2012-06-27       Impact factor: 4.798

6.  Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study.

Authors:  Maki Inoue; Kim Robien; Renwei Wang; David J Van Den Berg; Woon-Puay Koh; Mimi C Yu
Journal:  Carcinogenesis       Date:  2008-07-31       Impact factor: 4.944

7.  Response of serum and red blood cell folate concentrations to folic acid supplementation depends on methylenetetrahydrofolate reductase C677T genotype: results from a crossover trial.

Authors:  Cheryl A M Anderson; Shirley A A Beresford; Dale McLerran; Johanna W Lampe; Samir Deeb; Ziding Feng; Arno G Motulsky
Journal:  Mol Nutr Food Res       Date:  2013-03-04       Impact factor: 5.914

Review 8.  Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview.

Authors:  Anna E Beaudin; Patrick J Stover
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

9.  MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer.

Authors:  Valli De Re; R Cannizzaro; V Canzonieri; E Cecchin; L Caggiari; E De Mattia; C Pratesi; P De Paoli; G Toffoli
Journal:  Tumour Biol       Date:  2009-12-18

10.  Plasma homocysteine in adolescents depends on the interaction between methylenetetrahydrofolate reductase genotype, lipids and folate: a seroepidemiological study.

Authors:  Ruth Gil-Prieto; Valentín Hernández; Beatriz Cano; Manuel Oya; Angel Gil
Journal:  Nutr Metab (Lond)       Date:  2009-10-05       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.